Breast cancer, aromatase inhibitors, and bone health
Aromatase inhibitors (AIs) are a first-line therapy for postmenopausal women diagnosed with estrogen receptor-positive breast cancer. Because of the estrogen…
Breast Health
From the Journal
Implementing a Cancer Risk Assessment Screening Tool: Identifying Patients at Risk for Hereditary Breast and Ovarian Cancer Syndrome
The development and implementation of an HBOC risk assessment protocol can decrease morbidity and mortality.
Assessment and management of benign breast lesions: Role of the WHNP
“Benign Breast Conditions: The Role of the WHNP,” will be a breakout session at the 24th Annual NPWH Premier Women’s Health Conference Oct. 13 to 16. See article for registration details.
Caring for women on adjuvant therapy for breast cancer: Role of the NP in the primary care setting
Faculty: Rachel Gorham, MSN, WHNP-BC, AGN-BC, holds board certification as a women’s health nurse practitioner and in advanced genetics nursing.…
Understanding contralateral prophylactic mastectomy decision-making in women with early-stage breast cancer: A nursing perspective
August 1, 2019 A growing proportion of women with early-stage breast cancer without familial or genetic risk factors are electing…
